VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 137 filers reported holding VBI VACCINES INC in Q4 2021. The put-call ratio across all filers is 2.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $33,482 | -44.5% | 110,502 | -28.4% | 0.01% | -43.5% |
Q4 2022 | $60,328 | -55.6% | 154,251 | -20.1% | 0.02% | -61.7% |
Q3 2022 | $136,000 | +1260.0% | 193,000 | +1508.3% | 0.06% | +1100.0% |
Q2 2022 | $10,000 | -50.0% | 12,000 | 0.0% | 0.01% | -44.4% |
Q1 2022 | $20,000 | -28.6% | 12,000 | 0.0% | 0.01% | -25.0% |
Q4 2021 | $28,000 | – | 12,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
ArchPoint Investors | 65,000 | $202,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
Ergoteles LLC | 171,127 | $532,000 | 0.02% |
J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |